Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “PDS Biotechnology Corporation”

11 pharma patents match "PDS Biotechnology Corporation" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 11
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 11 pharmaceutical patents matching "PDS Biotechnology Corporation" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

11 results for “PDS Biotechnology Corporation” · 30,257 patents in full index Clear search

  1. US 11911359

    Stimulation of an immune response by cationic lipids

    PDS Biotechnology Corporation · Granted Feb 27, 2024 · Expires Feb 22, 2044

    granted
  2. US 11911465

    Vaccine compositions and methods of use

    PDS Biotechnology Corporation · Granted Feb 27, 2024 · Expires Feb 22, 2044

    granted
  3. US 11904015

    Vaccine compositions and methods of use

    PDS Biotechnology Corporation · Granted Feb 20, 2024 · Expires Feb 15, 2044

    granted
  4. US 11801257

    Stimulation of an immune response by enantiomers of cationic lipids

    PDS Biotechnology Corporation · Granted Oct 31, 2023 · Expires Oct 26, 2043

    granted
  5. US 11638753

    Lipids as synthetic vectors to enhance antigen processing and presentation ex-vivo in dendritic cell therapy

    PDS Biotechnology Corporation · Granted May 2, 2023 · Expires Apr 27, 2043

    granted
  6. US 11612652

    Lipids as synthetic vectors to enhance antigen processing and presentation ex-vivo in dendritic cell therapy

    PDS Biotechnology Corporation · Granted Mar 28, 2023 · Expires Mar 23, 2043

    granted
  7. US 11401306

    HPV16 non HLA-restricted t-cell vaccines, compositions and methods of use thereof

    PDS Biotechnology Corporation · Granted Aug 2, 2022 · Expires Jul 28, 2042

    granted
  8. US 10702541

    Stimulation of an immune response by enantiomers of cationic lipids

    PDS Biotechnology Corporation · Granted Jul 7, 2020 · Expires Jul 2, 2040

    granted
  9. US 9789129

    Stimulation of an immune response by enantiomers of cationic lipids

    PDS Biotechnology Corporation · Granted Oct 17, 2017 · Expires Oct 12, 2037

    granted
  10. US 8877206

    Stimulation of an immune response by cationic lipids

    PDS Biotechnology Corporation · Granted Nov 4, 2014 · Expires Oct 30, 2034

    granted
  11. US 7303881

    Antigen delivery compositions and methods of use

    PDS Biotechnology Corporation · Granted Dec 4, 2007 · Expires Nov 29, 2027

    granted